Press Release | Dr. Leen Kawas, CEO of EIT Pharma, Highlights on EASL Congress 2026
- Jun 30
- 1 min read
This press release profiles Dr. Leen Kawas as the executive behind EIT Pharma's lonafarnib program, offering a closer look at her background across drug development, venture investing, and biotech company building alongside the firm's EASL Congress 2026 presentations.
Comments